Ian Taylor Ph.D.
Net Worth
Last updated:
What is Ian Taylor Ph.D. net worth?
The estimated net worth of Dr. Ian Taylor Ph.D. is at least $12,018,976 as of 23 Feb 2024. He owns shares worth $1,053,307 as insider, has earned $7,019,469 from insider trading and has received compensation worth at least $3,946,200 in Arvinas, Inc..
What is the salary of Ian Taylor Ph.D.?
Dr. Ian Taylor Ph.D. salary is $657,700 per year as Chief Scientific Officer in Arvinas, Inc..
How old is Ian Taylor Ph.D.?
Dr. Ian Taylor Ph.D. is 62 years old, born in 1963.
What stocks does Ian Taylor Ph.D. currently own?
As insider, Dr. Ian Taylor Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Arvinas, Inc. (ARVN) | Chief Scientific Officer | 147,522 | $7.14 | $1,053,307 |
What does Arvinas, Inc. do?
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.
Ian Taylor Ph.D. insider trading
Arvinas, Inc.
Dr. Ian Taylor Ph.D. has made 17 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 1,701 units of ARVN stock worth $80,032 on 23 Feb 2024.
The largest trade he's ever made was exercising 25,000 units of ARVN stock on 5 Apr 2021. As of 23 Feb 2024 he still owns at least 147,522 units of ARVN stock.
Arvinas key executives
Arvinas, Inc. executives and other stock owners filed with the SEC:
- Dr. Ian Taylor Ph.D. (62) Chief Scientific Officer
- Dr. John G. Houston Ph.D. (65) Chief Executive Officer, Pres & Director
- Mr. Sean A. Cassidy CPA, M.B.A., CPA (55) Chief Financial Officer & Treasurer